Cambridge-based venture Sano Genetics (formerly known as Heterogeneous) has raised £500k seed funding for “an innovative research platform tipped to transform drug discovery and accelerate the growth of personalised medicine.” Patrick Short, CEO of the company, said: “We want to build the platform that will make personalised medicine a reality.” The startup was previously on the Accelerate Cambridge programme run by the Entrepreneurship Centre.
Read the full article [businessweekly.co.uk]
Brain food 
Compass 
Entrepreneurship 
In the media 
Network 
News 
Reasons why 
The lowdown 
Thinkers
Comments